Udita Samuel

To ensure Federal Policies, in particular transport policy, is mindful of of the economic, consumera and community interests of Nieuport Aviation

Advocating for upholding Canada's commitments to international human rights. Advocating for the protection of freedom of religion in Canada and with respect to the reasonable accommodation of religious observances. Advocating for stronger legislation to address hate crime and online hate. Advocating for policy initiatives related to combating Islamophobia and discrimination; Supporting various programs to protect fundamental freedoms in Canada. Advocating for policies to enhance the security and safety of Canadian Muslim communities and other at-risk communities given the rise in hate crimes; countering supremacist violent extremist groups

To ensure federal policies, in particular transport policy is mindful of the economic, consumer and community interests of Nieuport Aviation

Advocating for Federal investment and public transit initiatives across Canada

Promotion de l'avancement de la cybersécurité dans les transports publiques. Advocating for the rail sector in relation to changes to clean technology investment tax credit. Recherche de financement via le programme de fonds stratégiques pour l'innovation (FSI) afin d'offrir des solutions ferroviaires innovantes. Establishment or modification of appropriate regulations regarding trade. Research and Development funding for advanced manufacturing and developing mobility low to zero carbon technologies. Infrastructure projects related to transit systems, including rolling stocks and signalling. Establishment or modification of appropriate regulations regarding public transportation.

Through Innovation, Science & Industry discuss opportunities to enhance the Canadian life sciences sector including, biomanufacturing, partnerships, R&D investments. The Canada-European Union Comprehensive Economic and Trade Agreement (CETA) negotiations with respect to biopharmaceuticals and intellectual property right protection. Scientific Research and Experimental Development (SR&ED) Tax Incentive Program with regard to expansion of eligible expenditures to recognize the impact on innovation and the research and development (R&D) investment by the pharmaceutical industry in Canada. Science and Technology (S&T) Strategy with regard to ensuring that the implementation of that strategy encourages a public policy environment that attracts business investment in innovation and enhances the ability of Canadian industry to compete internationally. Representation with Ministry of Health and Public Service Procurement Canada to achieve emergency approval, procurement and utilization of the AZD1222 vaccine (Covishield) and long-acting antibody (LAAB) combination AZD7442 to fight the Covid-19 pandemic. Public policy issues related to Health Canada's review of NCE Patented Medicines Price Review Board (PMPRB) with regard to ensuring that PMPRB Guidelines, Policies and Procedures reflect PMPRB mandate to ensure that prices charged for patented medicines in Canada are not excessive and that potential changes consider impact to the pharmaceutical industry. Patented Medicines (Notice Of Compliance) Regulations with regard to ensuring that Canada's intellectual property (IP) laws and regulations are internationally competitive and continue to provide a stable and predictable business environment to encourage continued pharmaceutical investment in Canada. Patented Medicine Prices Review Board (PMPRB) with regard to ensuring guidelines also provide incentives for innovation through research and development in addition to PMPRB mandate of protection from excessive prices. National Pharmaceutical Strategy (NPS) with regard to ensuring development or implementation of any policies or programs include consultations with all affected stakeholders and focus on bettering access to medicines for Canadians. Cost Recovery Initiative, ensuring a framework where user fees adequately fund a safe and efficient review process. Canada's Food and Consumer Safety Action Plan with regard to ensuring that patient safety is a priority in a modern, efficient and internationally harmonized regulatory system that must be evidence-based, efficient and continuous while supporting timely access to innovative medicines and vaccines for Canadians, protecting intellectual property rights and preserving competitive research advantage. Canada's Access to Medicines Regime (CAMR) with regard to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease. Blueprint for Renewal with regard to ensuring a modern, efficient and internationally harmonized regulatory system that must be evidence-based, efficient and continuous while supporting timely access to innovative medicines and vaccines for Canadians, protecting intellectual property rights and preserving competitive research advantage.

Scientific Research and Experimental Development (SR&ED) Tax Incentive Program regarding eligible expenditures. Discussions on policies such as "patent box" and Investment Tax Credits. Public Health and prevention programs including the Public Health Agency of Canada and efforts to support the development and procurement of innovative vaccines and therapies to address major public health issues such as pandemic preparedness and RSV Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Federally-funded public drug plans, including the Non-Insured Health Benefits Program, Canadian Armed Forces Drug Benefit List and veteran programs, with respect to reimbursement for drug products for beneficiaries Establish accountability with Health Canada, Canada's Drug Agency and the pan-Canadian Pharmaceutical Alliance, as well as Regulations, policies and programs related to the review and reimbursement processes Engage with Canadian government officials to discuss and provide input on Canada's countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry, as well as free trade agreements as they relate to the biopharmaceutical industry Engagement with the government regarding the Strategic Response Fund (SRF) (previously known as SIF) and investment in Canada Canada’s Drug Agency policies and processes as it relates to reimbursement recommendation decision-making process and framework Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry Annual federal Budgets and Budget updates relating to the biopharmaceutical industry

CVCA previously co-administered the Start Up Visa Program's Venture Capital stream in partnership with the IRCC. The program allowed Venture Capital funds in CVCA's membership to apply for designated entity status and recommend entrepreneurs and start ups in their portfolio to apply for Canadian permanent residency. Throughout CVCA's contractual relationship with IRCC, the program led to a select and curated number of entrepreneurs growing businesses in Canada with financial backing. CVCA engaged in ongoing conversations with IRCC and provided regular reports. IRCC terminated all SUV contractual relationships in 2024, however, CVCA remains engaged in proactive conversations with IRCC Program officials who oversee the SUV program and who have relationships with CVCA's designated members. CVCA sees value in this program and maintains communication with IRCC on possible future improvements. The CVCA advocates for policies and a regulatory environment that is conducive to stimulating investment. A competitive tax and investment regime that rewards the risks associated with the private capital asset?class is vital for the growth of private equity and venture capital across economic sectors. CVCA’s efforts ensure Canadian companies can access necessary funding amidst challenges such as tightening credit markets, competition for capital, and economic uncertainties, to drive innovation and economic growth, ultimately fostering a resilient and diversified economy for future generations. CVCA also advocates for sustained and predictable access to capital, championing public-private co-investment initiatives. The Venture Capital Action Plan/Venture Capital Catalyst Initiative is still rolling out, matching private capital allocations to disbursed government dollars. CVCA continues to engage with industry and government to ensure awareness within the VC ecosystem and monitoring the flow of funds, underscoring the importance of Canada's VC Emerging Managers and their important role in allocating capital to riskier and underserved corners of the innovation ecosystem. The CVCA actively advocates for a strong and competitive tax and investment environment that attracts and rewards private investment in Canadian entrepreneurial ventures. We provide valuable insights and data to support effective tax policies. Strategically crafted policies can ensure that Canada remains an attractive destination for private capital, which is necessary to drive economic growth, job creation, and innovation. CVCA engages with policymakers to convey perspectives from the private capital industry, and the current economic context.

CVCA previously co-administered the Start Up Visa Program's Venture Capital stream in partnership with the IRCC. The program allowed Venture Capital funds in CVCA's membership to apply for designated entity status and recommend entrepreneurs and start ups in their portfolio to apply for Canadian permanent residency. Throughout CVCA's contractual relationship with IRCC, the program led to a select and curated number of entrepreneurs growing businesses in Canada with financial backing. CVCA engaged in ongoing conversations with IRCC and provided regular reports. IRCC terminated all SUV contractual relationships in 2024, however, CVCA remains engaged in proactive conversations with IRCC Program officials who oversee the SUV program and who have relationships with CVCA's designated members. CVCA sees value in this program and maintains communication with IRCC on possible future improvements. CVCA was a designated entity by the IRCC to co-administer the Start Up Visa Program, through which Venture Capital funds in CVCA's membership could support entrepreneurs and start ups applying for Canadian permanent residency. This program led to a select and curated number of entrepreneurs growing businesses in Canada, with financial backing. Throughout the program, CVCA engaged in ongoing conversations with IRCC to ensure program continuity. CVCA sees value in reinstating this program and maintains communication with IRCC on possible future improvements. The CVCA advocates for policies and a regulatory environment that is conducive to stimulating investment. A competitive tax and investment regime that rewards the risks associated with the private capital asset?class is vital for the growth of private equity and venture capital across economic sectors. CVCA’s efforts ensure Canadian companies can access necessary funding amidst challenges such as tightening credit markets, competition for capital, and economic uncertainties, to drive innovation and economic growth, ultimately fostering a resilient and diversified economy for future generations. CVCA also advocates for sustained and predictable access to capital, championing public-private co-investment initiatives. The Venture Capital Action Plan/Venture Capital Catalyst Initiative is still rolling out, matching private capital allocations to disbursed government dollars. CVCA continues to engage with industry and government to ensure awareness within the VC ecosystem and monitoring the flow of funds, underscoring the importance of Canada's VC Emerging Managers and their important role in allocating capital to riskier and underserved corners of the innovation ecosystem. The CVCA actively advocates for a strong and competitive tax and investment environment that attracts and rewards private investment in Canadian entrepreneurial ventures. We provide valuable insights and data to support effective tax policies. Strategically crafted policies can ensure that Canada remains an attractive destination for private capital, which is necessary to drive economic growth, job creation, and innovation. CVCA engages with policymakers to convey perspectives from the private capital industry, and the current economic context. The CVCA advocates for policies that secure access to capital, vital for the growth of private equity and venture capital across economic sectors. CVCA’s efforts ensure Canadian companies can access necessary funding amidst challenges such as tightening credit markets, competition for capital, and economic uncertainties, to drive innovation and economic growth, ultimately fostering a resilient and diversified economy for future generations. Venture Capital Action Plan/Venture Capital Catalyst Initiative is still rolling out, matching private capital allocations to disbursed government dollars. CVCA continues to engage with industry and government to ensure awareness within the VC ecosystem and monitoring the flow of funds, underscoring the importance of Canada's VC Emerging Managers an

Monitoring for any changes to the output-based pricing system and its provincial equivalency, and any related programs that advance or impede emissions-reducing technologies. Input regarding policies that enhance or impede the competitiveness of Canada's agriculture and fertilizer industries. Ensuring the ongoing reliability of the transportation supply chain. Advancing economically and environmentally sustainable agriculture practices including nutrient management protocols.

Assisting Toronto Busines Development Centre with funding applications and the start-up visa program

Charitable Sector Reform writ large. Includes engaging with government on necessary reform to enable the sector to flourish. Seeking non-monetary support from the Public Service in regards to the employee charitable giving campaign. Funding for community services and programs for children, youth, seniors, low income individuals, people seeking employment, newcomers, women and other community members. Budget with respect to: -investment in community services infrastructure -the community services labour force -housing and homelessness -mental health and other services -enabling measures for the work of charitable and nonprofit sector.

Raise awareness with elected and departmental officials about the work that Windmill is doing to support immigrants, newcomers and refugees. Explore opportunities for federal referral partnership. Discuss what we can all do to facilitate labour market integration for skilled immigrants and explore opportunities for new program and additional federal funding.

Raise awareness with elected and departmental officials about the work that Windmill is doing to support immigrants, newcomers and refugees. Discuss what we can all do to facilitate labour market integration for skilled immigrants and explore opportunities for new program and additional federal funding. Also, explore opportunities for federal referral partnership.